REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Krupaortesis y Protesis CIA Ltda (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Krupaortesis y Protesis CIA Ltda Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Krupaortesis y Protesis CIA Ltda is a wholesale distributor of prosthetic and orthotic medical technology. The company aims to provide O&P products in Ecuador. They have a team with over 25 years of combined experience in improving global access to orthotic and prosthetic services and orthopedic technology.

Headquarters
Miravalle N24988 , Floor 24988
Quito; Pichincha;

Contact Details: Purchase the Krupaortesis y Protesis CIA Ltda report to view the information.

Website: http://www.krupaop.com

Basic Information
Total Employees:
Purchase the Krupaortesis y Protesis CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Krupaortesis y Protesis CIA Ltda report to view the information.
Registered Capital:
Purchase the Krupaortesis y Protesis CIA Ltda report to view the information.
Incorporation Date:
September 01, 2010
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
95%
Purchase this report to view the information.
5%
Company Performance
Financial values in the chart are available after Krupaortesis y Protesis CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-32.96%▼
Total operating revenue
-32.96%▼
Operating profit (EBIT)
92.18%▲
Net Profit (Loss) for the Period
N/A
Total assets
-22.09%▼
Total equity
-92.72%▼
Operating Profit Margin (ROS)
35.7%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
677.69%▲
Quick Ratio
-0.84%▼
Cash Ratio
-0.37%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo